These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 32236609)
1. RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer. Matsumoto A; Shimada Y; Nakano M; Oyanagi H; Tajima Y; Nakano M; Kameyama H; Hirose Y; Ichikawa H; Nagahashi M; Nogami H; Maruyama S; Takii Y; Ling Y; Okuda S; Wakai T Oncol Rep; 2020 Jun; 43(6):1853-1862. PubMed ID: 32236609 [TBL] [Abstract][Full Text] [Related]
2. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107 [TBL] [Abstract][Full Text] [Related]
3. Association of RNF43 Genetic Alterations With BRAF Vogel A; Murugesan K; Kendre G; Quintanilha JCF; Ross JS; Brummer T; Saborowski A JCO Precis Oncol; 2024 Feb; 8():e2300411. PubMed ID: 38394466 [TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of BRAF Non-V600E Mutations in Colorectal Cancer: A Retrospective Study of Two Institutions. Shimada Y; Tajima Y; Nagahashi M; Ichikawa H; Oyanagi H; Okuda S; Takabe K; Wakai T J Surg Res; 2018 Dec; 232():72-81. PubMed ID: 30463788 [TBL] [Abstract][Full Text] [Related]
5. RNF43 frameshift mutations contribute to tumourigenesis in right-sided colon cancer. Lai C; Sun W; Wang X; Xu X; Li M; Huang D; Xu E; Lai M; Zhang H Pathol Res Pract; 2019 Aug; 215(8):152453. PubMed ID: 31122752 [TBL] [Abstract][Full Text] [Related]
7. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244 [TBL] [Abstract][Full Text] [Related]
8. Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation. Tie J; Gibbs P; Lipton L; Christie M; Jorissen RN; Burgess AW; Croxford M; Jones I; Langland R; Kosmider S; McKay D; Bollag G; Nolop K; Sieber OM; Desai J Int J Cancer; 2011 May; 128(9):2075-84. PubMed ID: 20635392 [TBL] [Abstract][Full Text] [Related]
9. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status. Jang MH; Kim S; Hwang DY; Kim WY; Lim SD; Kim WS; Hwang TS; Han HS J Korean Med Sci; 2017 Jan; 32(1):38-46. PubMed ID: 27914130 [TBL] [Abstract][Full Text] [Related]
10. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer. Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131 [TBL] [Abstract][Full Text] [Related]
13. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers. Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495 [TBL] [Abstract][Full Text] [Related]
14. BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features. Roma C; Rachiglio AM; Pasquale R; Fenizia F; Iannaccone A; Tatangelo F; Antinolfi G; Parrella P; Graziano P; Sabatino L; Colantuoni V; Botti G; Maiello E; Normanno N Cancer Biol Ther; 2016 Aug; 17(8):840-8. PubMed ID: 27261210 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer. Nakaji Y; Oki E; Nakanishi R; Ando K; Sugiyama M; Nakashima Y; Yamashita N; Saeki H; Oda Y; Maehara Y J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042 [TBL] [Abstract][Full Text] [Related]
16. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer. Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis. Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233 [TBL] [Abstract][Full Text] [Related]